Alpha Cubed Slashes Oracle Holdings by 59.8% to $12.61M
Alpha Cubed Investments LLC reduced its Oracle stake 59.8% in Q3, selling 66,714 shares and retaining 44,825 shares worth $12.61M. Insiders disposed of 62,223 shares valued at $12.14M over the quarter, while Oracle reported Q2 EPS of $2.26 on $16.06B revenue and declared a $0.50-per-share dividend for a 1.2% yield.
1. Alpha Cubed Investments Significantly Reduces Stake
During the third quarter, Alpha Cubed Investments LLC slashed its position in Oracle Corporation by 59.8%, disposing of 66,714 shares and retaining 44,825 shares at quarter end. According to the firm’s latest SEC filing, the remaining shares carry a notional value of $12.61 million. This divestiture contrasts sharply with moves by smaller managers: Darwin Wealth Management LLC boosted its holding by 130.0% to 115 shares, Winnow Wealth LLC initiated a position worth approximately $28,000, and Financial Consulate Inc., Corundum Trust Company INC and Kilter Group LLC each established new stakes ranging from $30,000 to $39,000. In aggregate, institutional investors and hedge funds now control 42.44% of Oracle’s outstanding stock.
2. Robust Quarterly Results and Shareholder Return
In its most recent quarter, Oracle outperformed earnings estimates by delivering $2.26 in EPS versus the consensus of $1.64, with revenue of $16.06 billion—a 14.2% increase year-over-year—just shy of the $16.19 billion consensus. Profitability remains strong, with a 25.28% net margin and a return on equity of 70.60%. The board declared a quarterly dividend of $0.50 per share, marking a $2.00 annualized payout and a 1.2% yield, supported by a payout ratio of 37.59%. The company’s balance sheet shows a debt-to-equity ratio of 3.28 and a current ratio of 0.91, reflecting its leveraged capital structure and working-capital position.
3. Analyst Consensus and Price Targets
Wall Street sentiment tilts toward the bullish side: among 41 analysts covering Oracle, three assign a Strong Buy, twenty-five a Buy, eleven a Hold and two a Sell rating, yielding a consensus of Moderate Buy. Average price targets set by brokerage firms stand at approximately $300.46, with recent upgrades from Goldman Sachs (Strong Buy) and reaffirmations from Deutsche Bank, while Royal Bank of Canada and Sanford C. Bernstein have trimmed their objectives. Equities analysts expect full-year EPS of around 5.00 for the current fiscal cycle.